The U.S.-China Program for Biomedical Collaborative Research was established in December 2010 by the U.S. National Institutes of Health and the National Natural Science Foundation of China to foster and expand biomedical research of benefit to both countries.
The program is accepting applications to support collaborative basic, translational, and applied research in the areas of allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities and co-infections, cancer, mental health, Parkinson’s disease, and stroke. Letters of intent are due on August 18, 2012, and applications are due on September 18, 2012.
For more information about the program, see the funding opportunity announcement number RFA-AI-12-021 and frequently asked questions.
RFA-AI-12-021: U.S.-China Program for Biomedical Collaborative Research (R01)
Peer Review at NIAID, Questions and Answers -- NIAID Research Funding
Peer Review at NIAID
Questions and Answers
Table of ContentsGeneral
- What award types are peer reviewed at NIAID?
- Does NIAID review many investigator-initiated applications?
- Is NIAID peer review similar to CSR peer review?
- Is scientific review group membership confidential?
- Where do I find rosters for NIAID's chartered review committees?
- I am responding to an RFA—where do I find rosters for NIAID's ad hoc review committees?
- If I respond to an NIAID program announcement, can I request a scientific review group?
- How does NIH handle conflict of interest?
- When should I contact reviewers?
- If I'm sending a paper application, how do I know it was assigned to the correct initiative?
- Will NIAID review late applications?
- Do NIAID scientific review officers check my application to make sure it's complete?
- May I send supplementary, missing, or corrected materials after a receipt date?
- What if I can't find the answer to my question in the opportunity announcement or on this page?
- Where can I find more questions and answers about applying and peer review?
- What if my question wasn't answered here, or I'd like to suggest a question?
Questions for Individual Opportunities
RFA-AI-12-021, U.S.-China Program for Biomedical Collaborative Research (R01)- What is the purpose of the U.S.-China Program for Biomedical Research Cooperation?
- What is NSFC?
- What are NSFC's eligibility requirements for Chinese collaborators?
- What are NIH’s eligibility requirements for U.S. applicants?
- May applicants outside the U.S. apply for funding from NIH?
- May federal institutions apply for funding?
- May NIH intramural investigators apply for funding?
- What research areas does this initiative support?
- May U.S. investigators apply with a pathogen or research area that is not listed in the announcement?
- How do a U.S. investigator and a Chinese collaborator create an application?
- Does the Chinese collaborator’s NSFC application need to be submitted as part of the NIH application?
- Do U.S. investigators need to include their Chinese collaborators' budgets in their applications?
- Do U.S. investigators need to share confidential or proprietary information with their Chinese collaborators?
- Can NIH staff send confidential or proprietary application information to a Chinese collaborator on behalf of an applicant?
- What is the maximum budget that U.S. applicants can request?
- How much funding can Chinese collaborators request from NSFC?
- Can NIH funds awarded under this program support expenses incurred in China but not included in the Chinese collaborator's project expenses?
- How do U.S. institutions pay for facilities and adminstrative costs for Chinese collaborators?
- Can NIH help U.S. applicants obtain approval from the Chinese government to export biospecimens out of China?
- Are electronic signatures acceptable in the letter of support or other submitted documents?
- Are references included in the 12-page limit for the research strategy?
- Are preliminary data required for this opportunity?
- What are the data sharing requirements?
- Will applicants receive feedback from NIH?
- How will NIH review applications?
- How will NSFC review applications?
- Will reviewers consider the Chinese collaborator’s scientific background when evaluating a U.S. investigator's application?
- Should a U.S. applicant include the Chinese collaborator’s biosketch?
- Must U.S. applicants show evidence of collaboration history with their Chinese collaborators?
- Does a U.S. applicant have to hold an active NIH grant?
- May a U.S. applicant submit more than one application on different projects, each with a different Chinese collaborator?
- Does the research have to be conducted in both the U.S. and China?
- Whom should I contact if I have a question regarding this announcement?
General
Read the questions and answers below or see the Table of Contents above.What award types are peer reviewed at NIAID?
NIAID oversees initial peer review for the following award types:- Applications in response to some program announcements, including most program announcements that identify location of peer review (PAR) and program announcements with set-aside funds (PAS).
- All applications responding to requests for applications.
- All applications for cooperative agreements and research center grants.
- Certain investigator-initiated applications, including program projects, training grants, career development awards, and clinical trials.
- Contract proposals received in response to solicitations.
Essentially NIAID and CSR conduct the same review with very minor differences.
To learn about peer review of initiatives, read Where are PAs and RFAs reviewed? and other entries in our RFAs, PAs, and Solicitations questions and answers. Also see the following SOPs:
Does NIAID review many investigator-initiated applications?
NIAID reviews a small number of investigator-initiated applications, including program projects, training grants, career development awards, and investigator-initiated clinical trial planning and implementation awards.Is NIAID peer review similar to CSR peer review?
The process is essentially equivalent.Is scientific review group membership confidential?
No. You can find many rosters online. See the next two questions.Where do I find rosters for NIAID's chartered review committees?
Find rosters for NIAID's chartered review committees at Councils and Committees:- Acquired Immunodeficiency Syndrome Research Review Committee
- Microbiology and Infectious Diseases Research Committee
- Allergy, Immunology, and Transplantation Research Committee
Though you can see the roster, you cannot request assignment (as you can with a CSR review committee) since there's only one group.
After the peer review meeting, you will get a roster with your summary statement. It will not tell you which panel members were assigned as primary and secondary reviewers (plus at least one additional reader), which is confidential information.
I am responding to an RFA—where do I find rosters for NIAID's ad hoc review committees?
You can find a roster for most ad hoc review committees for NIAID's requests for applications on NIH's Special Emphasis Panels page. We usually post the roster approximately one month before a review meeting.Check the site close to the meeting date stated in the RFA. If you still can't find the roster, contact the scientific review officer listed in the RFA notice. Also see Where do I find rosters for NIAID's chartered review committees? above.
If I respond to an NIAID program announcement, can I request a scientific review group?
That depends. If NIAID is to review your application, you usually cannot request a review group because typically only one group will review applications. Read the Guide notice to find out who is conducting the peer review.If CSR is to review your application, you can and should request a study section. If you don't, NIH will assign your application for you. For more on that, plus links to advice, go to Requesting an Institute and Study Section in the Strategy for NIH Funding.
How does NIH handle conflict of interest?
NIH and the institutes follow standard procedures to prevent program officers, peer reviewers, or advisory Council members who may have a real or apparent conflict of interest with an applicant from participating in a peer review.Members of peer review committees must leave the room during discussions of applications or contract proposals in which they or close associates have an interest that could bias their evaluations.
For details, see the Conflict of Interest in Peer Review SOP and Basic Layout of a Peer Review Meeting in the Strategy for NIH Funding.
When should I contact reviewers?
Never. See When should I contact reviewers? in the Peer Review of Applications questions and answers.If I'm sending a paper application, how do I know it was assigned to the correct initiative?
You can see this information in the Commons along with other assignment information. Check periodically and the information will appear.Will NIAID review late applications?
See NIAID's Late Applications SOP.Do NIAID scientific review officers check my application to make sure it's complete?
Yes. See SROs Assess Completeness, Assign Reviewers in the Strategy for NIH Funding.May I send supplementary, missing, or corrected materials after a receipt date?
Possibly. When submitting an application responding to an RFA, get in touch with the peer review contact person listed in the FOA or the scientific review officer to find out what you are allowed to do.What if I can't find the answer to my question in the opportunity announcement or on this page?
Contact the staff person listed in the request for applications.Where can I find more questions and answers about applying and peer review?
See the Application, Peer Review, and NIAID Program Project (P01) Applications questions and answers.What if my question wasn't answered here, or I'd like to suggest a question?
Email mailto:deaweb@niaid.nih.gov?Subject=Q and A feedback&Body=(Please include the Q and A title or a link in your message.) with the title of this page or its URL and your question or comment. We answer questions by email and post them here. Thanks for helping us clarify and expand our knowledge base.Questions for Individual Opportunities
RFA-AI-12-021, U.S.-China Program for Biomedical Collaborative Research (R01)NIH published this RFA in an April 4, 2012, Guide notice.
What is the purpose of the U.S.-China Program for Biomedical Research Cooperation?
The U.S.-China Program for Biomedical Collaborative Research stimulates collaborative basic, translational, and applied research between investigators from the U.S. and China in allergy, immunology, and infectious diseases, including HIV/AIDS and its comorbidities and coinfections, cancer, mental health, Parkinson’s disease, and stroke.U.S. and Chinese investigators work together to identify projects that address the research objectives and funding requirements described in the April 4, 2012, Guide notice.
What is NSFC?
NSFC is the National Natural Science Foundation of China. For more information, visit NSFC's Web site in Chinese or English.What are NSFC's eligibility requirements for Chinese collaborators?
Chinese collaborators must be current or former NSFC grantees. For a searchable database of funded NSFC investigators (in Chinese), go to NSFC's Internet-based Science Information System
.Potential collaborators and scientists in Special Administrative Regions of China (e.g., Hong Kong) should contact NSFC to discuss their eligibility requirements.
For more details on eligibility requirements for Chinese collaborators, go to the NSFC Funding Opportunity Announcement (in Chinese).
What are NIH’s eligibility requirements for U.S. applicants?
Read the April 4, 2012, Guide notice and note the following:- Chinese collaborators must be current or former NSFC grantees.
- To be considered for funding, both the U.S. and Chinese applications must be determined to be eligible and responsive by their respective organizations.
May applicants outside the U.S. apply for funding from NIH?
No. Foreign institutions and non-U.S. components of U.S. organizations may not apply for funding.Applications must list at least one investigator from a U.S. institution as the Program Director/Principal Investigator, and name the Chinese investigator as a collaborating partner.
May federal institutions apply for funding?
Yes. Note that federal institutions must ensure that their authorizing legislation allows them to receive NIH grants and comply with the terms and conditions of an NIH award.Contact your agency to find out if it is eligible.
May NIH intramural investigators apply for funding?
No. However, they may apply to a separate U.S.-China Program for Biomedical Research Cooperation.For more information, contact:
- For NCI/CCR PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Janelle Cortner or David Goldstein.
- For NCI/DCEG PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Marianne Henderson.
- For NIAID PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact Mark Pineda and Gayle Bernabe.
- For NIMH PIs (in scientific areas other than HIV/AIDS and its comorbidities), contact the NIMH Referral Office at nimhreferral@mail.nih.gov.
- For NIH PIs working in the area of HIV/AIDS and its comorbidities, contact Bob Eisinger and Joan Romaine.
- For NIH PIs working in the areas of Parkinson’s Disease or stroke (in scientific areas other than HIV/AIDS and its comorbidities), contact Peggy Rollins.
What research areas does this initiative support?
This initiative supports research areas outlined in the Funding Opportunity Description in the April 4, 2012, Guide notice. It does not support the following research activities:- Clinical trials (because of NSFC’s policy restrictions).
- Research involving select agents.
- Cancer studies that do not have an infectious agent or disease component.
May U.S. investigators apply with a pathogen or research area that is not listed in the announcement?
Possibly, depending on the research focus (as indicated for each participating NIH institute) and its relevance to the intent of this initiative.Before submitting their applications, U.S. investigators should discuss research plans with a Scientific/Research Contact listed under Agency Contacts in the April 4, 2012, Guide notice.
Note, however, that certain restrictions to permissible scientific activities are defined in the announcement.
How do a U.S. investigator and a Chinese collaborator create an application?
A U.S. investigator and Chinese collaborator work together to create a joint application that they submit to their respective agencies as follows:- U.S. investigator submits his or her application to NIH and shares a copy with the Chinese collaborator.
- Chinese collaborator submits the same application to NSFC with additional information requested in the NSFC Funding Opportunity Announcement (in Chinese).
Does the Chinese collaborator’s NSFC application need to be submitted as part of the NIH application?
No.Do U.S. investigators need to include their Chinese collaborators' budgets in their applications?
No, but NIH encourages them to include this information (in English), as well as a budget for any activities that they plan to undertake in China, as separate, clearly marked attachments to their applications. Use the Other Attachments option on the Research and Related Other Project Information form.Do U.S. investigators need to share confidential or proprietary information with their Chinese collaborators?
Only if they include this information in their applications. PIs concerned about confidentiality or proprietary information should take the sharing requirement into account when deciding what information to include.Can NIH staff send confidential or proprietary application information to a Chinese collaborator on behalf of an applicant?
No. Only applicants can send this information to their collaborators.What is the maximum budget that U.S. applicants can request?
U.S. applicants can request up to $200,000 a year in total costs (direct plus facilities and administrative costs) for up to three years.How much funding can Chinese collaborators request from NSFC?
See the NSFC Funding Opportunity Announcement (in Chinese).Can NIH funds awarded under this program support expenses incurred in China but not included in the Chinese collaborator's project expenses?
Yes. U.S. applicants can spend funds in China under this announcement but should justify in their applications why such an expense is needed to complete their research projects. Further, a U.S. investigator's budget should not overlap with that of his or her Chinese collaborator.Before submitting an application, applicants should discuss budgets that propose to spend funds in China with a Scientific/Research Contact listed under Agency Contacts in the April 4, 2012, Guide notice.
How do U.S. institutions pay for facilities and adminstrative costs for Chinese collaborators?
U.S. institutions do not pay for facilities and administrative costs for their Chinese collaborators. However, they can include items needed at any foreign site (whether in China or elsewhere) as direct costs in their budgets.Chinese collaborators receive support directly from NSFC.
For more information on calculating facilities and administrative costs on an NIH grant, contact your institution's business office and read Where do I find guidance on calculating facilities and administrative costs? in our Managing a Grant questions and answers.
Can NIH help U.S. applicants obtain approval from the Chinese government to export biospecimens out of China?
No. U.S. applicants should work closely with their Chinese collaborating investigators, who are responsible for obtaining the necessary approvals.If the proposed research requires exporting biospecimens from China, U.S. applicants must include the following information in their applications:
- Type of biospecimens to be exported.
- Evidence that the applicant has already applied for the required Chinese government approval to export these materials.
- Indication of whether the work can be completed if the Chinese government does not grant this approval.
Are electronic signatures acceptable in the letter of support or other submitted documents?
No. Documents must have original signatures, which are then scanned and submitted.Are references included in the 12-page limit for the research strategy?
No.Are preliminary data required for this opportunity?
No.What are the data sharing requirements?
All applications should follow the NIH Data Sharing Policy and Implementation Guidance.For applications proposing research on Parkinson’s disease (PD) on U.S. patients:
- All genetic studies must share data using dbGaP.
- All laboratory-based PD studies on human specimen and clinical PD biomarker projects, including imaging studies, must comply with NINDS Parkinson's Disease Biomarkers Program (PDPB) Strategy requirements.
- U.S. grantees may have to deposit some human biological samples collected under this program into the NINDS Human Genetics DNA and Cell Line Repository
- When planning an application, U.S. investigators should follow the approval process in China for international sharing of the biological samples and genetic data.
Will applicants receive feedback from NIH?
Yes, they will receive feedback in the form of summary statements after peer review of their applications.How does NIH review applications?
NIH assigns applications to scientific review groups convened by NIAID, National Cancer Institute, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke, in accordance with NIH peer review policy and procedures, using the review criteria listed in the April 4, 2012, Guide notice. Applicants can see their review assignments in the eRA Commons after they apply.NIH makes funding decisions based on the research priorities of the U.S.-China program.
.png)
No hay comentarios:
Publicar un comentario